Thursday, 12 March 2009

LMS Postpones Review for another 30 Days

LMS Medical Systems (LMZ - TSX)
Shares outstanding: 25.8m
Fully Diluted: 30.7 million

The TSX announced today, that it has again extended the review of LMS’ listing for another 30 days.

An approval to maintain a TSX listing hinges upon on LMS’ ability to raise money. We speculate that the TSX would have ceased trading the stock if it did not believe that LMS was having meaningful discussions that could result in a capital injection.

Stay tuned…

To view the full release, click here…